These results were presented today at the San Antonio Breast Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
News
- LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit ... - BioSpace
- Breast cancer researcher receives outstanding investigator award - Healio
SAN ANTONIO — Christina Curtis, PhD, MSc, received this year's AACR ... The work can be conducted in any biomedical research discipline, including ...
- Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist ...
... San Antonio Breast Cancer Symposium 2024, currently underway in San Antonio, Texas. ... Editorial · Sarepta, Biotech's Regulatory Go-Getter, Signs ...
- Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as ...
... San Antonio Breast Cancer Symposium (SABCS) today, Wednesday, December ... Harnessing the power of biotechnology, chemistry and genetic ...
- ICAD, Inc. Announces Presentation Of Four Novel AI-Driven Breast Cancer Research ...
... Biotechnology Stocks · Blockchain Stocks · Bullish Moving Averages · Bearish ... San Antonio Breast Cancer Symposium. These studies emphasize ...